Ginkgo to Acquire Zymergen - Yahoo Finance
7/25/2022 12:00:00 AM2 years 9 months ago
by PR Newswire
by PR Newswire
Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced...
- Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology platform
- Expect integration of Zymergen's complementary automation, softwar… [+15905 chars] full article...